Barbara Hibner
Impact in
-
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
-
- Melanoma and MAPK Pathways
- DNA Repair Mechanisms
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Cancer therapeutics and mechanisms
Papers in
-
- Melanoma and MAPK Pathways 2
-
- Cancer Mechanisms and Therapy 3
- Genetic factors in colorectal cancer 2
- Co-authors
- John F. Lyons (2 shared papers)Gideon Bollag (1 shared paper)S M Wilhelm (1 shared paper)Thomas H. Eickbush (1 shared paper)William D. Burke (1 shared paper)Katherine G. Rendahl (3 shared papers)Sylvia Ma (1 shared paper)Thomas G. Gesner (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)The Journal of Immunology (1 paper)Genetics (1 paper)Japanese Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Barbara Hibner
11 papers receiving 499 citations
Peers
Comparison fields: 5 of 59
- Oncology 223
- Molecular Biology 391
- Cancer Research 59
- Pathology and Forensic Medicine 68
- Hematology 30
Countries citing papers authored by Barbara Hibner
This map shows the geographic impact of Barbara Hibner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Hibner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Hibner more than expected).
Fields of papers citing papers by Barbara Hibner
This network shows the impact of papers produced by Barbara Hibner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Hibner. The network helps show where Barbara Hibner may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Hibner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 314 | |
| 2 | 2007 | 117 | |
| 3 | 1991 | 45 | |
| 4 | 2017 | 11 | |
| 5 | 2001 | 11 | |
| 6 | 1996 | 7 | |
| 7 | 2006 | 5 | |
| 8 | 1993 | 4 | |
| 9 | Optimization of the anti-tumor activity of tezacitabine in combination with fluoropyrimidines in human colon carcinoma cell lines and xenografts | 2004 | 2 |
| 10 | 2004 | 2 | |
| 11 | 2013 | 1 |
About Barbara Hibner
Barbara Hibner is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Cancer Research and Organic Chemistry, having authored 11 papers that have together received 519 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Genomics and Diagnostics (2 papers), Genetic factors in colorectal cancer (2 papers), Melanoma and MAPK Pathways (2 papers), Personality Disorders and Psychopathology (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (223 citations), Molecular Biology (391 citations), Cancer Research (59 citations), Pathology and Forensic Medicine (68 citations) and Hematology (30 citations). Barbara Hibner has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include John F. Lyons, Gideon Bollag, S M Wilhelm, Thomas H. Eickbush, William D. Burke, Katherine G. Rendahl, Sylvia Ma, Thomas G. Gesner, Tahir Sheikh and Archie Tse. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, The Journal of Immunology, Genetics and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.